<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01381770</url>
  </required_header>
  <id_info>
    <org_study_id>plt-msl001</org_study_id>
    <nct_id>NCT01381770</nct_id>
  </id_info>
  <brief_title>Platelet-derived Factors for Treatment of Muscular Lesions</brief_title>
  <official_title>Platelet-derived Factors for Treatment of Muscular Lesions: a Phase II Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate that platelet-derived repairing factors are
      effective and safe in the treatment of muscular lesion grade 2 or 3, a Phase II, open-label,
      single arm, single centre has been designed. Sample size will be 25.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number (and proportion with 95% CI) of patients able to return to sport activity (i.e. training) at 21 days from muscular injury.</measure>
    <time_frame>21 days from enrollment</time_frame>
    <description>If the athlete is able, 21 days after the muscular injury, to return to (at least) training activities, the outcome will be coded &quot;successful&quot;; and &quot;unsuccessful&quot; otherwise</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time-to-return to sport activities</measure>
    <time_frame>within 4 months from lesion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>within 4 months from treatment</time_frame>
    <description>Overall frequency of patients with any adverse events (number, proportion and 95%CI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time-to-healing at ultrasound</measure>
    <time_frame>within 4 months from treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>within 4 months from treatment</time_frame>
    <description>types of side effects (number, proportion and 95%CI for each type of adverse events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>within 4 months from treatment</time_frame>
    <description>grade of side effects (number, proportion and 95%CI for each grade of adverse events)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Muscle Lesions</condition>
  <arm_group>
    <arm_group_label>Platelet-derived repairing factors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>platelet-derived repairing factors</intervention_name>
    <description>autologous platelet lysate injection within 24 hours from lesion</description>
    <arm_group_label>Platelet-derived repairing factors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years old

          -  if woman, no pregnancy ongoing

          -  muscular lesion grade 2 or 3 in a lower limb muscular group

        Exclusion Criteria:

          -  no hematological conditions

          -  no anticoagulation in the two preceding weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinica Ortopedica Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2011</study_first_submitted>
  <study_first_submitted_qc>June 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2011</study_first_posted>
  <last_update_submitted>August 24, 2015</last_update_submitted>
  <last_update_submitted_qc>August 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Matteo</investigator_affiliation>
    <investigator_full_name>Claudio Pavesi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>muscular lesions grade 2</keyword>
  <keyword>muscular lesions grade 3</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

